CGEM
Price
$7.87
Change
-$0.29 (-3.55%)
Updated
Jun 20, 11:27 AM (EDT)
Capitalization
481.56M
48 days until earnings call
SLRN
Price
$2.27
Change
+$0.04 (+1.79%)
Updated
May 20 closing price
Capitalization
229.16M
60 days until earnings call
Interact to see
Advertisement

CGEM vs SLRN

Header iconCGEM vs SLRN Comparison
Open Charts CGEM vs SLRNBanner chart's image
Cullinan Therapeutics
Price$7.87
Change-$0.29 (-3.55%)
Volume$200
Capitalization481.56M
ACELYRIN
Price$2.27
Change+$0.04 (+1.79%)
Volume$4.08M
Capitalization229.16M
CGEM vs SLRN Comparison Chart in %
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. SLRN commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Hold and SLRN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (CGEM: $8.16 vs. SLRN: $2.27)
Brand notoriety: CGEM and SLRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 83% vs. SLRN: 173%
Market capitalization -- CGEM: $481.56M vs. SLRN: $229.16M
CGEM [@Biotechnology] is valued at $481.56M. SLRN’s [@Biotechnology] market capitalization is $229.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileSLRN’s FA Score has 1 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • SLRN’s FA Score: 1 green, 4 red.
According to our system of comparison, CGEM is a better buy in the long-term than SLRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 6 TA indicator(s) are bullish.

  • CGEM’s TA Score: 6 bullish, 4 bearish.

Price Growth

CGEM (@Biotechnology) experienced а -9.13% price change this week, while SLRN (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

CGEM is expected to report earnings on Aug 07, 2025.

SLRN is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($482M) has a higher market cap than SLRN($229M). SLRN YTD gains are higher at: -27.707 vs. CGEM (-33.005). CGEM has higher annual earnings (EBITDA): -208.62M vs. SLRN (-324.52M). SLRN has more cash in the bank: 562M vs. CGEM (304M). CGEM has less debt than SLRN: CGEM (1.84M) vs SLRN (6.56M). CGEM (0) and SLRN (0) have equivalent revenues.
CGEMSLRNCGEM / SLRN
Capitalization482M229M210%
EBITDA-208.62M-324.52M64%
Gain YTD-33.005-27.707119%
P/E RatioN/AN/A-
Revenue00-
Total Cash304M562M54%
Total Debt1.84M6.56M28%
TECHNICAL ANALYSIS
Technical Analysis
CGEM
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 17 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.440.45
+1.96%
GameStop Corp
TSLA322.055.70
+1.80%
Tesla
AAPL196.580.94
+0.48%
Apple
SPY597.53N/A
N/A
SPDR® S&P 500® ETF
BTC.X104684.290000-199.039060
-0.19%
Bitcoin cryptocurrency

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-1.92%
MDGL - CGEM
50%
Loosely correlated
+1.12%
DNLI - CGEM
47%
Loosely correlated
-3.63%
FATE - CGEM
46%
Loosely correlated
+0.83%
BEAM - CGEM
46%
Loosely correlated
+1.92%
IDYA - CGEM
45%
Loosely correlated
-0.27%
More

SLRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRN has been loosely correlated with CMND. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SLRN jumps, then CMND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRN
1D Price
Change %
SLRN100%
N/A
CMND - SLRN
38%
Loosely correlated
-1.15%
THAR - SLRN
36%
Loosely correlated
-0.69%
IDYA - SLRN
35%
Loosely correlated
-0.27%
CGEM - SLRN
35%
Loosely correlated
-1.92%
STOK - SLRN
34%
Loosely correlated
-0.77%
More